This section provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Investor information is released in Swedish for regulatory reasons and translated into English on a report-to-report basis. Please contact Redsense for additional information.
Press Releases
Redsense Medical to focus on core growth areas, discontinuing trading on OTCQX
Nomination committee appointed for the 2025 Annual General Meeting in Redsense Medical AB
Redsense Medical AB (publ) appoints a new CEO
Member of the board of Redsense Medical AB resigns
Chairman of the board of Redsense Medical AB resigns - Acting chairman of the board appointed
Interim Report Q2 – January – June, 2024 Redsense Medical AB (publ.)
Major shareholding notification
Redsense has secured a new order worth MSEK 6.99
Major shareholding notification
The Board of Directors in Redsense Medical AB (publ) resolves to carry out a directed share issue of MSEK 7,5.
The CEO leaves Redsense Medical AB
Major shareholding notification
Major shareholding notification
Redsense Medical presents at Sedermeradagen Stockholm 2024
Redsense Medical Spotlight presentation at the 61[st] ERA Congress in Stockholm
Kommuniké från årsstämma i Redsense Medical AB (publ) den 8 maj 2024
Interim Report Q1 – January – March, 2024 Redsense Medical AB (publ.)
Redsense Medical welcomes new investment from ShapeQ to accelerate growth
The Board of Directors in Redsense Medical AB (publ) resolves to carry out a directed share issue of approximately MSEK 9,8.
Redsense Medical attending Home Dialysis Congress in Germany
Uppdatering: Redsense Medical AB (publ) årsredovisning 2023, nu med bilagd årsredovisning i pdf
Redsense Medical AB (publ) årsredovisning 2023
Förtydligande: Redsense Medical AB (publ) upplyser att punkt 13 har omformulerats och att veckodagarna som datumen infaller på har uppdaterats.
KALLELSE TILL ÅRSSTÄMMA I REDSENSE MEDICAL AB (PUBL)
Home Dialysis Risk Prevention Act addressed in House Committee on Ways and Means Hearing
Redsense Medical presents at Redeye Theme: Commercialization in Life Science
Redsense Medical attending US dialysis conferences this spring
Meet Redsense Medical at the Swiss Nordic Bio 2024
Correction: Missing MAR-lable in previous press release - "Year-End Report – January – December, 2023 Redsense Medical AB (publ)"
Year-End Report – January – December, 2023 Redsense Medical AB (publ)
Redsense Medical presents at Stora AktiedagarnaStockholm
American Association of Kidney Patients supports the Home Dialysis Risk Prevention Act
AAKP Says Medicare Should Prioritize Safety Innovation [read more]